204 related articles for article (PubMed ID: 8876934)
41. Cardiovascular effects of a new dihydropyridine calcium antagonist.
Kimura Y; Fukui H; Tanaka M; Okamoto M; Miura A; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1336-44. PubMed ID: 3790183
[TBL] [Abstract][Full Text] [Related]
42. A new Ca-antagonist, azelnidipine, reduced blood pressure during exercise without augmentation of sympathetic nervous system in essential hypertension: a randomized, double-blind, placebo-controlled trial.
Arita M; Hashizume T; Tanigawa K; Yamamoto H; Nishio I
J Cardiovasc Pharmacol; 1999 Feb; 33(2):186-92. PubMed ID: 10028925
[TBL] [Abstract][Full Text] [Related]
43. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
Ogura C; Ono K; Miyamoto S; Ikai A; Mitani S; Sugimoto N; Tanaka S; Fujita M
Blood Press; 2012 Dec; 21(6):367-71. PubMed ID: 22747420
[TBL] [Abstract][Full Text] [Related]
44. [Effects of fenigidin treatment regimen on the state of peripheral hemodynamics of patients with stable effort angina pectoris and postinfarction cardiosclerosis].
Boev SS
Ter Arkh; 1998; 70(12):17-9. PubMed ID: 10067243
[TBL] [Abstract][Full Text] [Related]
45. [Hemodynamic effects of the new calcium antagonist nimodipine in normal and increased blood pressure].
Engberding R; Bender F; Gülker H; Specker E; Molinski M
Z Kardiol; 1984 Aug; 73(8):498-503. PubMed ID: 6495809
[TBL] [Abstract][Full Text] [Related]
46. Molsidomine in the treatment of patients with angina pectoris.
Majid PA; DeFeyter PJ; Van der Wall EE; Wardeh R; Roos JP
N Engl J Med; 1980 Jan; 302(1):1-6. PubMed ID: 6985697
[TBL] [Abstract][Full Text] [Related]
47. [Clinico-functional characteristics of stenocardia and the effectiveness of its treatment with nitrong and erinit].
Volkov VS; Bratoliubov VP
Ter Arkh; 1986; 58(5):124-7. PubMed ID: 3090730
[TBL] [Abstract][Full Text] [Related]
48. Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: the Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (SIDAMI) trial.
Andersen MJ; Ersbøll M; Axelsson A; Gustafsson F; Hassager C; Køber L; Borlaug BA; Boesgaard S; Skovgaard LT; Møller JE
Circulation; 2013 Mar; 127(11):1200-8. PubMed ID: 23406672
[TBL] [Abstract][Full Text] [Related]
49. Effects of intravenous verapamil on the haemodynamic response to exercise in patients with angina pectoris.
Sadick N; Roubin GS; Harris PJ; Hiroe M; Meares S; Bautovich G; Kelly DT
Acta Med Scand Suppl; 1984; 681():91-8. PubMed ID: 6587758
[TBL] [Abstract][Full Text] [Related]
50. [The action of a new calcium antagonist 5,6-dimethoxy-2-(3 [(alpha-(3,4-dimethoxy)-phenylethyl)methylamino] propyl)-phthalimidine hydrochloride (AQ-A 39cl) on hemodynamics and ischemia parameters in exercise ECG of patients with coronary heart disease].
Jost S; Schulz W; Kober G
Arzneimittelforschung; 1985; 35(8):1279-82. PubMed ID: 4074444
[TBL] [Abstract][Full Text] [Related]
51. Anti-ischaemic and haemodynamic effects of elgodipine, a potent new generation calcium antagonist, in chronic stable angina.
Acharya DU; Senior R; Basu S; Harrison F; Galiano A; Lahiri A
Eur Heart J; 1994 May; 15(5):665-71. PubMed ID: 8056008
[TBL] [Abstract][Full Text] [Related]
52. Cardiovascular selectivity of 1,4-dihydropyridine derivatives, efonidipine (NZ-105), nicardipine and structure related compounds in isolated guinea-pig tissues.
Masuda Y; Miyajima M; Shudo C; Tanaka S; Shigenobu K; Kasuya Y
Gen Pharmacol; 1995 Mar; 26(2):339-45. PubMed ID: 7590084
[TBL] [Abstract][Full Text] [Related]
53. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
[TBL] [Abstract][Full Text] [Related]
54. Captopril or nifedipine? Comparison of rest and exercise acute effects and long-term therapy in chronic isolated asymptomatic moderate to severe aortic regurgitation.
Banaszewski M; Rydlewska-Sadowska W; Rubkiewicz S
J Heart Valve Dis; 1998 Sep; 7(5):488-99. PubMed ID: 9793844
[TBL] [Abstract][Full Text] [Related]
55. Effects of nicorandil on left ventricular hemodynamics and volume at rest and during exercise-induced angina pectoris.
Silke B; Verma SP; Ali MS; Goldhammer E; Taylor SH
Am J Cardiol; 1989 Jun; 63(21):49J-55J. PubMed ID: 2525326
[TBL] [Abstract][Full Text] [Related]
56. Clinical, electrocardiographic, and hemodynamic effects of ICI 89,406, a new cardioselective beta-adrenoceptor antagonist with intrinsic sympathomimetic activity, in patients with angina pectoris.
Majid PA; Schreuder JE; de Feyter PJ; Roos JP
J Cardiovasc Pharmacol; 1980; 2(4):435-44. PubMed ID: 6156341
[TBL] [Abstract][Full Text] [Related]
57. Effect of exercise and isoprenaline on left ventricular ejection fraction in patients with angina pectoris as assessed by radionuclide angiography.
Sapru RP; Muir AL; Hannan WJ; Smith HJ; Brash HM; Wraith PK
Cardiology; 1982; 69(2):91-7. PubMed ID: 7105072
[TBL] [Abstract][Full Text] [Related]
58. Effect of efonidipine, a novel dihydropyridine derivative, on myocardial metabolic changes induced by coronary artery ligation in dogs: comparison with nifedipine.
Yokoyama T; Ichihara K; Abiko Y
Fundam Clin Pharmacol; 1997; 11(3):245-51. PubMed ID: 9243256
[TBL] [Abstract][Full Text] [Related]
59. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
Tanaka H; Shigenobu K
Cardiovasc Drug Rev; 2002; 20(1):81-92. PubMed ID: 12070536
[TBL] [Abstract][Full Text] [Related]
60. Effects of nicardipine on cardiac volume at rest and during exercise-induced angina.
Silke B; Verma SP; Frais MA; Hafizullah M; Taylor SH
Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):169S-176S. PubMed ID: 2862901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
